Ventricular arrhythmia risk due to chloroquine/hydroxychloroquine treatment for COVID-19: Should it be given
Author:
Open Access
- 1 March 2020
- journal article
- letter
- Published by Elsevier in Indian Heart Journal
- Vol. 72 (2) , 131-132
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trialInternational Journal of Antimicrobial Agents, 2020
- Drug treatment options for the 2019-new coronavirus (2019-nCoV)BioScience Trends, 2020
- Development and Validation of a Risk Score to Predict QT Interval Prolongation in Hospitalized PatientsCirculation: Cardiovascular Quality and Outcomes, 2013
- Determinants of Prolonged QT Interval and Their Contribution to Sudden Death Risk in Coronary Artery DiseaseCirculation, 2009